From the Scientific and Clinical Directors . . .
We are pleased to bring you the Winter 2007 issue of IRPartners.
The issue begins with a story about the NIAMS Career Development
section and its chief, Mario Cerritelli, Ph.D. This department
plays a critical role in sustaining NIAMS’ pool of scientific
talent, and serves as an access point, advocate and resource
for intramural trainees and candidates.
You’ll also learn about new faces and happenings at
the NIAMS Cardozo community health center, and recent activities
with the NIAMS Health Partnership Program. In addition, we
feature IRP staff members who have recently been honored with
professional awards, as well as a synopsis of IRP research
highlights from the past several months.
Also of interest are our new information resources, including
an interactive Web tool that can help identify one’s
personal risk for osteoporosis, a CD-ROM containing a wide
array of bone health fact sheets, and a brochure on bursitis
We hope you enjoy this issue, and we look forward to sharing future highlights and advances with you.
John O’Shea, M.D.
Intramural Research Program
National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health
Daniel Kastner, M.D., Ph.D.
Intramural Research Program
National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health
NIAMS Career Development
Section – A Conversation with Mario Cerritelli,
Dr. Mario Cerritelli has a broad interest in math and science
that dates back to his early years in a New Jersey high school,
where he excelled in these subjects. At Rutgers University,
he took numerous scientific courses and graduated with a double
major in chemistry and zoology. After college he worked for
two years in the R&D laboratories of a small pharmaceutical
company developing a new toothpaste for sensitive teeth. For
part of this work, he was located off-site at the Columbia
University School of Medicine and Dentistry in New York. It
was during this time that he decided to pursue a graduate
degree in molecular biology.
Dr. Cerritelli received his Ph.D. in molecular biology and
biochemistry from the State University of New York at Stony
Brook and conducted research at Brookhaven National Laboratory
on Long Island, N.Y. Subsequently, Dr. Alasdair Steven recruited
him to the NIAMS to work in the Laboratory of Structural Biology
Research (LSBR). While there, he made critical contributions
to the understanding of viral structure and maturation, including
a landmark Cell paper showing for the first time how phage
DNA is packed inside the viral head. His work has been featured
on the cover of this and other journals over the years. In
addition to his research in the LSBR, he also got involved
in the mentoring of fellows and students, and participated
in many of the Institute’s outreach initiatives. In
2002, after a formal national search, he was selected as chief
of the newly created NIAMS Career Development Section, where
he has developed an outstanding training program. During his
tenure at the NIH, Dr. Cerritelli received a number of honors
Dr. Cerritelli and his wife, also a NIH career scientist,
moved from Long Island to Bethesda with their seven-month-old
daughter. Today, the family has grown to a total of five children,
ages 7 - 16. When it comes to guiding the fellows and students
in the NIAMS, Dr. Cerritelli is often complimented for his
patience and nurturing character. In response, he is often
quick to point out, “Having five children at home has
helped me to improve my communication skills.”
In this issue of IRPartners, Dr. Cerritelli responds to several
questions regarding the NIAMS Career Development Section.
Q. What is the goal of the NIAMS Career Development Section?
A. We strive to provide all NIAMS fellows and students with
an exceptional training program and an overall enjoyable and
productive experience in our Intramural Research Program.
The CDS provides guidance and advice in all matters regarding
NIAMS fellows’ training and mentoring, and assists with
all aspects of career development, following established and
innovative ways to enhance their educational experience.
Q. What types of training opportunities are available at
A. The NIAMS IRP is dedicated to training a new generation
of scientists. We actively seek candidates at all stages in
their careers who want to learn the latest advances in basic
and clinical research. We offer numerous training opportunities
to high school students, college students, and graduate and
medical students, through our summer and year-round fellowship
programs. Postdoctoral fellowships provide the opportunity
for recent doctoral recipients to enhance their research skills
in NIAMS labs. The Rheumatology Fellowship Training Program
trains physicians wishing to pursue careers in biomedical
or translational research. We also offer postbaccalaureate
training in our laboratories and clinics, including at our
community health center located in Washington, D.C.
Q. What resources do you offer?
A. The CDS offers a global approach to career development,
one that includes the development of career skills tailored
to the individual needs of the fellow. We organize lectures,
discussions and workshops on topics relevant to career development,
such as scientific communication, knowledge of grants and
negotiation strategies, teaching, job hunting and networking.
We also maintain a collection of career books and training
materials that can be borrowed or viewed online via a virtual
bookcase that even offers an online checkout option. Our approach
to individualized career development includes one-on-one counseling
focusing on the more practical aspects of careers and success
to help young scientists develop a roadmap or plan that is
custom designed around their specific needs and interests.
After an evaluation process that provides feedback and help
in assessing one’s specific strengths and weaknesses,
I provide advice on job options and opportunities that fit
well with the individual’s lifestyle and temperament.
Q. Can you describe some of your program’s outreach
A. The goal in many of our outreach efforts is to encourage
young students to pursue careers in the biomedical sciences
and to create a workforce at NIAMS that reflects the rich
diversity of our nation. Besides some of our more established
programs, such as our Adopt-a-School activities, minority
research conference exhibits and career fair presentations,
we are always exploring new approaches to develop a greater
community awareness and appreciation of science and scientific
research careers, and to encourage the public to pursue training
in these areas. This past year we started several exciting
initiatives, one involving a partnership with the Montgomery
County Police Activities League (PAL) where we worked with “at
risk” children to highlight academic achievement and
provide them with research scientists as positive role models.
It was great to see the glow of excitement in the faces of
these children as they toured NIAMS laboratories, attended
a lecture on the immune system and constructed 3-D models
based on virus design. Another new initiative involves the
newly formed NIH Warrior Transition Team. This NIH-wide initiative,
headed by Dr. John O’Shea and me, is designed to provide
wounded service members with the opportunity to transition
back into the workforce. While undergoing treatment at the
Walter Reed Army Medical Center, participants can train at
the NIH on a part-time basis until they are ready to seek
full-time permanent employment.
Q. Why is mentoring important to the young scientist?
A. If you ask most successful scientists about their career
path, they can always point to people to whom they go for
advice: their “mentors.” This trusted circle of
friends and advisors acts much like the board of directors
of a corporation that assists management with major decisions.
The major difference here is that this board is composed of
mentors whose only interest in serving is seeing that the
fellow is successful. While most young scientists have a research
advisor, many fellows find that they need more advice than
can comfortably be given by their advisor, or that their advisor
is not comfortable with this role. Moreover, it’s helpful
to have advice from several different sources. The Career
Development Section challenges fellows to examine their strengths
and weaknesses through the mentoring process.
Q. Can you tell us about the NIAMS Summer Internship Program?
A. The NIAMS Summer Internship Program provides an unparalleled
opportunity for high school students, undergraduates and graduate
and medical students to spend a summer working side by side
with some of our most accomplished scientists in an environment
that has a rich history of training leaders in the fields
of biomedical research. These students are exposed to a basic
science curriculum, career development skills, training options
and discussions of ongoing IRP research. In addition, we have
many fun and exciting field trips and on-campus social activities
that promote networking.
Q. What is the most rewarding aspect of your position?
A. I get great pleasure out of helping fellows and students
realize their fullest potential and leading them down their
unique paths to success. The young scientists bring a new
exciting perspective and youthful energy into our research
program. There are just so many choices and options. I help
direct, give advice and provide the tools they need for lifelong
Interactive Web Tool Offers Bone Checkup and
Osteoporosis Prevention Steps for Adults
Now, people can give their bones a checkup using NIAMS’ interactive
Web tool called Check Up On Your Bones. Based on
information from Bone Health and Osteoporosis: A
Report of the Surgeon General, the Web tool is designed
to help people understand how the information in this important
public health report relates to them as individuals.
Visitors to Check Up On Your Bones are invited to fill out
a 5-minute personal profile, which the Web tool uses to create
individualized information about each person’s risk
factors for osteoporosis as well as those factors that protect
their bones. The tool also generates personalized information
on steps they can take to keep their bones healthy and prevent
osteoporosis, a summary sheet to share with the doctor, and
a list of additional Web resources tailored to their profile.
The personal profile asks about factors related to people’s
risk for osteoporosis, including gender and age; family history
of osteoporosis and broken bones; lifestyle habits, including
diet and exercise; and other medical conditions and medications
that can negatively impact bones. Osteoporosis is a disease
that causes bones to become fragile and break easily, but
it can often be prevented by adopting lifelong habits to protect
“We tend to take our bones for granted and think osteoporosis
will never happen to us,” said NIAMS Director Stephen
I. Katz, M.D., Ph.D. “We think people who use this tool
will learn a lot about their bones and many will be surprised
to discover that they have some risk factors for osteoporosis.
Hopefully, they will be motivated to take better care of their
bones as a result.”
The Web tool is designed for adults aged 19 and older. Information
provided on the site is relevant for both men and women and
for people of diverse races and ethnicities. The personal
information that visitors provide on the Check Up On Your
Bones Web site is private. It is not saved, and visitors are
not asked for their names. The Web tool can be found at http://www.niams.nih.gov/Health_Info/Bone/Optool/index.asp.
Ankylosing Spondylitis Study Seeks Answers,
When Christian Drobnyk was about ten years old, he began
experiencing arthritis pain, mostly in his neck, but also
in his pelvis. His mother began doing research into what might
be wrong. Doctors found that Drobnyk carried a specific gene
marker, HLA-B27, which is linked to a disease called Ankylosing
Spondylitis (AS). The disease causes spinal joint inflammation,
which over time causes the bones of the spine to fuse, resulting
in difficulty performing daily activities. Although all the
indications suggested that he might have AS, Drobnyk’s
symptoms didn’t line up for an AS diagnosis for another
10 years. During this time, Drobnyk just wanted to figure
out how to get back outside and play soccer.
Through a local support group for the Spondylitis Association
of America, Drobnyk met Dr. Michael Ward, a rheumatologist
with NIAMS and principal investigator for a study of the genetic
determinants of the severity of AS. Drobnyk said he was happy
to come to the NIH Clinical Center to participate in Ward’s
study “to contribute to research so that the people
who grow up after me figure out what’s going on more
quickly and know how severe the condition is going to be.”
Three-fourths of patients with AS are men, and the disease
typically begins between the ages of 15 and 35. Inflammation
and fusion often start in the sacroiliac joint of the pelvis
and low back and later affect other parts of the spine. Bone
fusion does not occur in everyone with spondylitis, but in
severe cases the spine fuses solidly, often resulting in a
forward-stooped posture. AS patients must take care when exercising
or driving, as their backs and necks are fragile.
AS is not a rare disease—one in every 1,000 people
have it—but it can take several years to diagnose because
of the difficulty distinguishing mechanical back pain from
the inflammatory arthritis of AS. AS is more prevalent than
multiple sclerosis, cystic fibrosis, and Lou Gehrig’s
disease combined. AS patients may also develop other inflammatory
conditions, such as heart valve disease, inflammatory bowel
disease and uveitis, an eye inflammation.
Treatments for its symptoms include physical therapy and
exercise to preserve joint motion and flexibility, over-the-counter
and prescription nonsteroidal anti-inflammatory medications
(NSAIDs), and anti-TNF alpha drugs. There are currently no
medications that are known to halt the fusion process, and
patients progress at different rates, so developing a customized
treatment plan can be difficult. Ward hopes the study will
provide physicians with genetic markers to predict whether
a patient will have a slight or severe progression of the
disease and assist in treatment recommendations.
Patients enrolled in the study come to the NIH Clinical Center
every six months for examination of the joints, measurement
of flexibility of the spine, and blood tests. X-rays are taken
periodically. The study seeks to identify genes and genetic
markers associated with AS and genes that influence the severity
of AS. The HLA-B27 gene marker is present in 80 to 90 percent
of individuals with the disorder. It is believed that several
other genes also increase a person’s risk of AS, but
AS is not directly passed from parent to child.
Although Ward’s protocol does not provide treatment,
Drobnyk said that building knowledge for himself and future
patients through the study was a valuable experience for him. “The
more you participate in the study of your own disease, the
more you learn about it,” said Drobnyk, noting that
Dr. Ward answered his questions and monitored him during the
study. “You give and you take back.”
If you or someone you know has AS, contact the Patient Recruitment
and Public Liaison Office at 1-800-411-1222 or TTY 1-866-411-1010
about study #03-AR-0131. The NIH-sponsored study is available
to patients in locations other than Bethesda, Md. Participating
institutions include Cedars-Sinai Medical Center in Los Angeles,
the University of California, San Francisco, and the University
of Texas at Houston.
This article, authored by Jenny Haliski, appeared in
the August 2007 issue of NIH’s Clinical Center News.
NIAMS IRP Research in the News
Anti-Malarial Drug May Reduce Diabetes Risk in Patients with
Michael Ward, M.D., of the Office of the Clinical Director,
and a national team of investigators recently explored the
association between the antimalarial drug hydroxychloroquine
and the risk of diabetes mellitus in patients with rheumatoid
arthritis (RA). Their findings were reported in the Journal
of the American Medical Association. Investigators analyzed
data from the Arthritis, Rheumatism, and Aging Medical Information
System (ARAMIS), a data bank with information on thousands
of patients with rheumatic diseases (and healthy volunteers)
followed for over 25 years. An analysis indicated that individuals
with RA who had taken hydroxychloroquine had a lower risk
of developing diabetes mellitus, and that this risk was further
reduced the longer the drug was taken.
Wasko MC, et al. Hydroxychloroquine and risk of diabetes
in patients with rheumatoid arthritis. JAMA 2007;298(2):187-93.
Genes Identified That Increase Risk for Rheumatoid Arthritis
Elaine Remmers, Ph.D., of the NIAMS Genomics Section and
her colleagues recently reported on genes that increase the
risk of rheumatoid arthritis (TRAF1-C5) and the risk of rheumatoid
arthritis and systemic lupus erythematosis (STAT4). Their
findings were reported in the New England
Journal of Medicine.
The success of this work has been attributed to the uncommon
and longstanding collaboration between NIAMS intramural researchers
and scientists the Institute supports throughout the country.
(Both studies were further strengthened by contributions from
researchers in Sweden.) Scientists view the identification
of these genes as a significant advancement that could lead
to an enhanced ability to develop more specific diagnostic
tests and therapies for rheumatoid arthritis, lupus, and,
potentially, other autoimmune diseases.
Remmers EF, et al. STAT4 and the risk of rheumatoid arthritis
and systemic lupus erythematosus. NEJM 2007;357:977-986.
Plenge RM, et al. TRAF1-C5 as a risk locus for rheumatoid
arthritis - a genomewide study. NEJM 2007;357:1199-1209.
Scientists Gain New Insights into Immune-Regulating Cells
Arian Laurence, Ph.D., and his colleagues in the NIAMS Molecular
Immunology and Inflammation Branch recently reported important
findings related to the control of autoimmune T cells. Their
discoveries, described in the journal Immunity, have largely
to do with a cytokine, or chemical messenger, called interleukin-2
IL-2 has been seen as a stimulator of the immune system (it
is used in the treatment of some cancers), but it also has
inhibitory effects. Mice lacking IL-2 die from autoimmune
disease. The team found that IL-2 inhibits autoimmunity by
acting on different T cells with opposing functions.
Laurence A, et al. Interleukin-2 signaling via STAT5 constrains
T helper 17 cell generation. Immunity 2007;26(3):371-381.
Scientists Discover Role of Enzyme in DNA Repair
Investigators in the NIAMS Molecular Immunology and Inflammation
Branch, led by Rafael Casellas, Ph.D., made an important discovery
about the role of an enzyme called ataxia telangiectasia mutated
protein (ATM) in the body’s ability to repair damaged
DNA. (Casellas’ research focuses largely on certain
genes that are deliberately broken and repaired as part of
the immune response.) Investigators deduced that ATM enzymatic
activity interfered with the process of transcription near
areas of DNA damage, ensuring repair in an undisturbed environment.
This leaves open the possibility that, in the absence of these
factors, DNA repair is compromised – leading to genetic
aberrations. The work, reported in Nature, was a collaborative
effort with the National Cancer Institute.
Kruhlak M, et al. The ATM repair pathway inhibits RNA polymerase
I transcription in response to chromosome breaks. Nature 2007;447:730-734.
Study Sheds Light on Allergic Reaction Anaphylaxis
Ana Olivera, Ph.D., and her colleagues in the NIAMS Molecular
Inflammation Section recently reported that mice with high
blood levels of the molecule sphingosine-1-phosphate (S1P)
were very susceptible to anaphylaxis: a severe – and
potentially fatal – allergic response. Their findings
were reported in the journal Immunity. The team worked with
mice that could not produce sphingosine kinase 1 or sphingosine
kinase 2 (also called Sphk1 and Sphk2), two proteins that
mast cells activate when confronted by allergens. When the
team compared the responses of these mice with those of normal
mice, they found that anaphylaxis severity correlated with
circulating S1P levels. Investigators also learned that Sphk2
is required for producing S1P in mast cells, whereas S1P circulating
in the bloodstream is dependent on Sphk1. Sphk2 is also necessary
for calcium influx and protein kinase C activation, two critical
elements involved in the mast cells’ release of their
Olivera A, et al. The sphingosine kinase-sphingosine-1-phosphate
axis is a determinant of mast cell function and anaphylaxis.
NIAMS and Community Partners Celebrate
Community partners joined NIAMS researchers at the NIAMS
Health Partnership Program Community Partners Meeting on July
10. During the meeting, NIAMS staff provided updates on the
Health Partnership Program (HPP) 5-Year Plan, introduced a
new research protocol at the NIAMS Community Health Center
(CHC), and reviewed the patient enrollment criteria for clinical
studies at the CHC. Partners and NIAMS staff also discussed
strategies to improve minority access to health care and clinical
trials. This meeting was followed by a 6th anniversary celebration
of the CHC. Since the opening of the NIAMS CHC in July 2001,
more than 1,500 new patients have been enrolled into the Natural
History Study of Rheumatic Diseases in Minorities.
The community partners helped NIAMS create the HPP, a community-based
research initiative, and helped establish the CHC in Washington,
D.C. The partners provide the HPP with insight into the community’s
needs and concerns about health care and research. They also
share resources to help the HPP operate effectively in the
NIAMS Community Health Center
The NIAMS has set up the NIAMS Community Health
Center to help doctors and scientists understand the causes
of rheumatic diseases and why many of these diseases occur
more often and more severely in certain minority communities.
With this information, we can find better ways to treat and
prevent these diseases. There are no experimental treatments
or medications being used at the Community Health Center.
Call 202–673–0000 for information.
Honors and Awards
O’Shea Receives First “Making A Difference” Award
J. O’Shea, M.D., scientific director of the NIAMS
IRP and chief of the Molecular Immunology and Inflammation
Branch and the Lymphocyte Cell Biology Section, received the
first NIH Office of Equal Opportunity and Diversity Management “Making
a Difference” award. The honor was in recognition of “his
strong advocacy efforts for diversity across the NIH and his
outstanding example of the creative possibilities for enhancing
diversity within his Institute.” The award was presented
at the NIAMS Intramural Research Program Retreat in May. In
the photo above, Dr. O’Shea is shown addressing the
audience after receiving the honor.
Morasso Serves as Mentor for Women’s Health Internship
Maria I. Morasso, Ph.D., principal investigator of the Developmental
Skin Biology Unit at NIAMS, recently served as a mentor for
the Women’s Health Summer Internship Program funded
by the Foundation for the NIH through a grant from Clinique.
In summer 2007, three college students were chosen to join
this program through a rigorous selection process among many
competitive candidates. The training involved 8 to 10 weeks
of intensive biomedical research experience.
One of the three interns, Jean Suh, worked with Dr. Morasso.
Suh was then a freshman from the John Hopkins University,
majoring in biomedical engineering. In Morasso’s lab,
Suh worked directly under postdoctoral fellow Olivier Duverger,
Ph.D., studying genetics of skin cells of mice. Her experience
at NIH also included instruction on lab safety, a lecture
series and career development workshops. At the end of the
program, Suh and the other two interns presented their projects
at a poster day. Said Morasso, “It is a wonderful program;
I would recommend it to any students with special interests
in skin biology.”
Siegel Inducted into ASCI
NIAMS’ Richard M. Siegel, M.D.,
Ph.D., was recently
elected to the American Society for Clinical Investigation
(ASCI), “an honor society of physician-scientists, those
who translate findings in the laboratory to the advancement
of clinical practice.” Siegel, group leader of the Immunoregulation
Group in NIAMS’ Autoimmunity Branch, was one of sixty
new members inducted at the ASCI’s annual meeting in
April. His current research interests include the regulation
of cellular survival and death in the immune system by TNF
family receptors, and the manipulation of these signaling
pathways to treat autoimmune diseases. Siegel has also been
active in student training, directing the trans-NIH MD/PhD
partnership training program.
NIAMS Introduces Bone Health CD-ROM
NIAMS is now offering Bone
Health Information for You and Your Patients on a
CD-ROM. This CD-ROM was created to give health professionals
and the general public easy access to the latest information
on bone health and diseases. In the last decade, medical research
has influenced a rapid advancement in treatment options for
many diseases of bone. Through this CD, we hope to help a
variety of audiences learn more about bone diseases and strategies
to optimize bone health.
This CD-ROM includes:
- A collection of print-friendly PDF files of selected patient
- Professional educational resources, including
the full text of Bone Health and Osteoporosis: A Report
of the Surgeon General
- Web links to current clinical trials
and numerous useful resources from NIH, other federal agencies,
and nonprofit organizations.
Free copies are available to anyone upon request. Health
professionals, patients and family members, and health educators
will find this CD particularly useful. To order a free copy
of the CD-ROM, contact the NIAMS Clearinghouse at 1-877-22-NIAMS
(1-877- 226-4267), or firstname.lastname@example.org or visit http://www.niams.nih.gov.
NIAMS Welcomes New Staff Members
NIAMS welcomes several new staff members to the Health Partnership
Program and Cardozo Community Health Center:
Heather Christensen, M.S., N.P., joined NIAMS this year as
the nurse practitioner for the NIAMS’ Community Health
Center (CHC). Though much of her training is in primary care,
she has also received specialty training in orthopaedics,
dermatology, occupational health and urgent care. Heather
hails from San Francisco, where she graduated from a Masters
of Science program at the University of California, San Francisco.
Considering her role at the CHC, Heather shares, “I
am really looking forward to applying the skills and knowledge
that I have gained in my clinical and educational experiences
to my position as nurse practitioner here at the CHC. I am
hoping that the time I spend here at NIAMS will further enrich
my understanding of this interesting field, how rheumatologic
conditions affect our unique patient population, and how to
improve patients’ quality of life.” Prior to
becoming a nurse practitioner, she worked in environmental
toxicology on clinical research projects investigating health
conditions of former nuclear test site workers.
Melissa Fellman is the Spanish interpreter at the Community
Health Center. When she is not working with the patients and
doctors at the CHC, Melissa assists with administrative duties
such as scheduling patients, maintaining the library of health
information, and conducting her own research gathering demographic
information on the more than 1,500 patients treated at the
CHC. Melissa comes to NIAMS as a recipient of an Intramural
Research Training Award, a prestigious and competitive fellowship
program to train postbaccalaureates in basic or applied biomedical
research. Melissa received her undergraduate degree in 2006
from the University of Pennsylvania, and is applying for entrance
into an MD/MPH program for Fall 2008. Melissa has served as
a Spanish translator for more than five years at various free
medical clinics. What makes Cardozo different from the other
clinics, Melissa says, is that “we are able to offer
patients state-of-the-art health care, and on a regular basis.
Patients know that we are here to allow them to regain functioning,
decrease pain, and improve their lives overall. As the reputation
of the clinic grows and patients come in earlier in their
disease progression, we can begin to provide early treatment
for patients with rheumatic diseases and thus change the idea
of what it means to have rheumatoid arthritis, lupus or osteoarthritis
in this community.”
Mark F. Gourley, M.D., joined the NIAMS as the director of
the Rheumatology Fellowship Training Program, and is overseeing
clinical care at the NIAMS Cardozo Community Health Center. “The
NIAMS CHC is more than a doctor’s office,” Dr.
Gourley stated. “It is a team of health care professionals
that provides exceptional rheumatology care to individuals
who may otherwise not have access to this specialized service.” Dr.
Gourley served as a staff clinician at the NIH’s National
Institute of Environmental Health Sciences (NIEHS), where
he worked with a team of researchers investigating environmental
causes of lupus and other autoimmune diseases. His research
interest in lupus began in 1988 when he first joined NIH/NIAMS.
He left NIAMS in 1996 to open the Greater Washington, D.C.
area’s first lupus clinic at the Washington Hospital
Center. Dr. Gourley is a 1985 graduate of Tulane Medical School
and completed his internal medicine residency in 1988 at the
University of Wisconsin.
NIAMS welcomes Mimi Lising, M.P.H., to the Office of Communications
and Public Liaison. Mimi took over after Kelli Carrington’s
departure to manage the NIAMS Health Partnership Program.
She also serves as a multicultural health educator for NIAMS,
helping to expand its library of health information for racial
and ethnic minority groups. “What makes NIAMS unique,” Mimi
reflects, “is that even though it is the world’s
leader in biomedical research in joint, bone, skin, and muscle
diseases, NIAMS still keeps its roots in the community by
serving the health needs of people in the metropolitan Washington
D.C. area through the Community Health Center.” Mimi
was a former NIH presidential management intern and a public
health educator with the National Institute of Diabetes and
Digestive and Kidney Diseases, where she helped to establish
the National Kidney Disease Education Program and the National
Diabetes Education Program. Before joining NIAMS, Mimi worked
at Kaiser Permanente, creating patient and health professional
education materials for such conditions as diabetes, asthma,
cardiovascular disease and chronic pain. Mimi is originally
from Southern California, where she graduated with a Masters
of Public Health degree from the University of California,
NIAMS Launches Booklet About Bursitis
Bursitis and tendinitis are both common conditions that involve
inflammation of the soft tissue around muscles and bones,
most often in the shoulder, elbow, wrist, hip, knee or ankle.
NIAMS recently released the brochure Questions
and Answers About Bursitis and Tendinitis. The booklet provides a comprehensive
overview of bursitis and tendinitis, including the causes
and types, how these conditions are diagnosed and treated,
and current research directions.
To order a free copy of the brochure, contact the NIAMS Clearinghouse
at 1-877-22-NIAMS (1-877-226-4267), or email@example.com or visit
National Institute of Arthritis
and Musculoskeletal and Skin Diseases/NIH
Building 31, Room 4C02
31 Center Drive, MSC 2350
Bethesda, MD 20892-2350
Produced by the National Institute of Arthritis
and Musculoskeletal and Skin Diseases/NIH
Office of Communications and Public Liaison
Building 31, Room 4C02
31 Center Drive
Bethesda, MD 20892
Web site: www.niams.nih.gov
Stephen I. Katz, M.D., Ph.D., Director
John O’Shea, M.D., Scientific Director
Daniel Kastner, M.D., Ph.D., Clinical Director
Janet S. Austin, Ph.D., OCPL Director
Ray Fleming, Editor
Trish Reynolds, Associate Editor
Mimi Lising, Sharon Nouzari Louis, Ping Wang